Pharmacokinetic/Pharmacodynamic Evaluation of Solithromycin against Streptococcus pneumoniae Using Data from a Neutropenic Murine Lung Infection Model.


Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
08 2019
Historique:
received: 31 12 2018
accepted: 09 05 2019
pubmed: 12 6 2019
medline: 9 6 2020
entrez: 12 6 2019
Statut: epublish

Résumé

Solithromycin (CEM-101) is a novel fluoroketolide antimicrobial agent with activity against typical and atypical pathogens associated with community-acquired bacterial pneumonia. Using a neutropenic murine lung infection model, the objectives of this study were to identify the pharmacokinetic/pharmacodynamic (PK/PD) index most closely associated with efficacy and the magnitude of such indices associated with solithromycin efficacy against

Identifiants

pubmed: 31182534
pii: AAC.02606-18
doi: 10.1128/AAC.02606-18
pmc: PMC6658793
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Macrolides 0
Triazoles 0
solithromycin 9U1ETH79CK

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2019 American Society for Microbiology.

Références

Antimicrob Agents Chemother. 2009 Dec;53(12):5060-3
pubmed: 19738006
Antimicrob Agents Chemother. 2010 Mar;54(3):1358-9
pubmed: 20038627
Thorax. 2012 Jan;67(1):71-9
pubmed: 20729232
Antimicrob Agents Chemother. 2001 Jan;45(1):13-22
pubmed: 11120938
J Pharmacokinet Pharmacodyn. 2001 Oct;28(5):481-504
pubmed: 11768292
Diagn Microbiol Infect Dis. 2005 May;52(1):45-52
pubmed: 15878442
Antimicrob Agents Chemother. 2016 Sep 23;60(10):6381-5
pubmed: 27458220
J Appl Physiol (1985). 1986 Feb;60(2):532-8
pubmed: 3512509
Clin Infect Dis. 2016 Oct 15;63(8):1007-1016
pubmed: 27448679
Antimicrob Agents Chemother. 2014;58(2):909-15
pubmed: 24277019
J Pharm Pharm Sci. 2007;10(1):37-50
pubmed: 17498392
Antimicrob Agents Chemother. 2012 Oct;56(10):5076-81
pubmed: 22802254
Antimicrob Agents Chemother. 2016 May 23;60(6):3662-8
pubmed: 27044551
Antimicrob Agents Chemother. 2009 May;53(5):2139-41
pubmed: 19258276
Antimicrob Agents Chemother. 2005 Sep;49(9):3944-7
pubmed: 16127078
Drug Metab Pharmacokinet. 2009;24(5):411-7
pubmed: 19881252
Antimicrob Agents Chemother. 2018 Jan 25;62(2):
pubmed: 29158271
Antimicrob Agents Chemother. 2006 Jan;50(1):243-9
pubmed: 16377693
Postgrad Med. 2010 Mar;122(2):130-41
pubmed: 20203464
Antimicrob Agents Chemother. 2017 Jul 25;61(8):
pubmed: 28559256
Lancet Infect Dis. 2016 Apr;16(4):421-30
pubmed: 26852726
Antimicrob Agents Chemother. 2008 Jan;52(1):24-36
pubmed: 17846133
Antimicrob Agents Chemother. 2017 Jan 24;61(2):
pubmed: 27872075

Auteurs

Olanrewaju O Okusanya (OO)

Institute for Clinical Pharmacodynamics, Inc., Schenectady, New York, USA.

Alan Forrest (A)

Institute for Clinical Pharmacodynamics, Inc., Schenectady, New York, USA.

Sujata M Bhavnani (SM)

Institute for Clinical Pharmacodynamics, Inc., Schenectady, New York, USA SBhavnani@icpd.com.

Prabhavathi Fernandes (P)

Cempra Pharmaceuticals, Inc., Chapel Hill, North Carolina, USA.

Paul G Ambrose (PG)

Institute for Clinical Pharmacodynamics, Inc., Schenectady, New York, USA.

David R Andes (DR)

Department of Medicine, Section of Infectious Diseases, University of Wisconsin School of Medicine, Madison, Wisconsin, USA.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH